COVID-19: Weekly Summary (November 17-23, 2025)

I would describe this week’s blog chatter about COVID-19 as a messy family dinner. Folks kept bringing plates to the table that didn’t quite match — some brought science, some brought politics, some brought historical takes, and one or two kept asking for money. To me, it feels like a neighborhood where everyone yells over the fence and half the conversation is about last year’s bad roof. If you poke through the posts from 11/17 to 11/23/2025, a few clear threads show up. They tangle together. They fray. But you can still pick out the pattern if you squint a bit.

The origins and how we talk about them

This week the most pointed, lively stuff came from people re-examining how the pandemic started and how institutions handled the story. The clearest example is the extended back-and-forth that centered on a Substack event previewed and then summarized by Jeremy Faust. The live discussion he hosted or promoted — and the follow-up write-up — wrestled with the NIH’s pandemic preparedness essay and pushed back on some of the institutional narratives.

I would describe these posts as trying to pry open a jammed door. They want more sunlight. They argue for careful evidence-based work on how COVID-19 got into people — zoonosis versus lab-leak debates — and they press that the science needs to be allowed to follow the evidence instead of being steered by politics. They keep circling the same point: origins matter. Not just for blame or for a weird moral satisfaction, but because the answer affects how we prepare next time.

To me, it feels like watching two neighbors argue about whether the fire started from a faulty heater or a tossed cigarette. Both explanations mean you change the house. One story means you ban heaters. The other means you ban smoking on porches. The recommendations diverge. The posts from Jeremy Faust and colleagues argued for following the trail of data — genetic clues, market sampling, lab records — and not tossing out lines of inquiry because they’re politically awkward.

There was also a repeated note about the politics of the lab-leak idea. The takedown of the NIH essay — which the live chat aimed to rebut — pulls at the thread of how agencies frame preparedness and which hypotheses they treat as legitimate. People in the thread say: when organizations close ranks or insist on a single story, public trust erodes. That point loops into other posts this week.

Trust, authority, and the old priesthood idea

A smaller but sharp essay by Nathan Knopp leaned into a longer, historical angle. He drew parallels between the Roman Catholic Church’s authority during the Black Death and modern scientific institutions during COVID-19. He suggested that both started as corrective rebellions and then ossified into an authoritative class.

I’d say this piece reads like someone walking into a cathedral and asking why the stained glass looks the same, century after century. Knopp sees cracks where others see continuity. He argues that rituals, peer review, reputations — all those things that give science authority — can also become the tools that hide mistakes or stave off accountability. He didn’t just fling a brick through a lab window. He traced a pattern.

This struck a chord with the takedown discussions. When scientists or agencies appear defensive, or when messaging changes in ways people find confusing, folks like Knopp and the Faust group say that trust gets chipped away. And chipped trust matters. It’s not just an academic complaint. It affects vaccine uptake, policy support, and how the public reacts in an emergency. Imagine the public as a driver relying on GPS. If the gadget keeps rerouting with no explanation, you stop trusting it. Same vibe.

There’s a stubborn, slightly cranky undertone in these posts. It’s not all measured policy-speak. It’s more like someone saying: we used to trust the doc. Now the doc acts like a bureaucrat. The tone matters. It’s human, not polished. A few posts hinted that this erosion of trust might reshape where people get their information next time.

Practical public health signals — data and the seasonal uptick

More matter-of-fact contributions this week leaned on surveillance and immediate health concerns. Caitlin Rivers posted a Thanksgiving outlook that reads like the kind of note a public-health person leaves on the fridge: calm, slightly urgent, and full of small details.

Her piece flagged that influenza activity was low but rising, especially among kids. She noted outpatient visits for influenza-like illness inching up and some early signs that COVID-19 and RSV were also starting to tick upward. H3N2 showed up as the dominant flu strain in her summary. And yes, there were side notes: food recalls, norovirus risk around Thanksgiving, and an odd, controversial bureaucratic move about vaccine information that she flagged. The USD-level policy stuff she reported was presented as a heads-up: be aware, protect kids, and watch for local spikes.

Then there was a local, boots-on-the-ground report from Gunnar Wolf. He wrote about a university vaccination event where roughly 31,000 people got shots for various diseases, including COVID-19. The tone is different from the high-flying policy debate. This is the clinic in the gym, the elbow-ink-and-sticker moment. He emphasized personal responsibility around big gatherings — namedrops DebConf and other conferences where people will pack into rooms — and encouraged attendees to get vaccinated. It’s practical. It’s plain. Like a neighbor reminding you to bring a coat because it’s going to be chilly at night.

Those two posts — the data note and the vaccination event — feel like the ground truth. They’re less interested in grand narratives and more interested in getting shots in arms, keeping hospitals from filling up, and nudging people to make good choices for Thanksgiving and holiday travel. They’re the sort of posts you might print out and tape to the office bulletin board.

Money, policy, and the COVID-era hangover

Policy chatter didn’t vanish. It shifted into the financial and legislative aftermath of the emergency. Tom Church had a focused piece about the GOP’s options for negotiating the temporary COVID-era ACA subsidies that were set to expire at the end of 2025.

His post boiled the choices down to a few practical moves: let the subsidies lapse, keep some subsidies for original ACA populations, redirect funds into Health Savings Accounts (HSAs), or revise ACA rules to nudge behavior and reduce costs. He framed it as typical Washington politicking — money on the table, trade-offs to be made, and political theater on top.

What I’d say is interesting here is the way COVID after-effects now live in budget lines and legislative calendars. This isn’t just virology anymore. It’s spreadsheets and negotiations. The pandemic pushed money into coverage expansions and temporary relief. Now those subsidies are a bargaining chip. For people on the ground — patients, clinics, state Medicaid offices — the choices matter a lot. For politicos, they become bargaining chips. It’s like when your local diner raises prices after a storm. Some customers grumble; some accept it; some stop coming.

Tom’s piece read like an economist on a porch, listing the chairs and asking who’s going to sit where next.

The recurring Zimmermania — space, fundraising, and pandemic rhetoric

A strange recurring cameo in the data dump was Robert Zimmerman. He had many posts this week about rockets and satellites and about supporting his website. But one consistent note threaded through several of his pieces: a critique of government performance during the COVID pandemic. In a dozen different posts — which otherwise mostly discussed rockets, launches, and space startups — Zimmerman keeps circling back to pandemic policy, government missteps, and his own perspective on how these things were handled.

I’d describe Zimmerman’s COVID mentions as the background hum on a radio. The main song might be about Vega-C rockets, SpaceX launches, or Mars avalanches, but now and then the speaker crackles and you hear a jab about emergency governance in 2020–2022. He uses those references to buttress a larger skepticism of big-government solutions and to make the case for private enterprise.

A couple of points to note: Zimmerman mixes nostalgia, skepticism, and fundraising requests. His COVID commentary is short on technical detail and more about assigning responsibility and framing historical judgment. If you’re interested in ticking through the space reporting, his site has a lot to chew on. If you’re interested in serious epidemiology, his pieces point to a broader political critique rather than deep virology.

The science-policy clash: rhetoric versus reality

Across the week, the posts form two camps that sometimes overlap. One camp wants to re-open questions about origins, hold institutions to account, and press for open debate. The other camp is more focused on immediate public-health tasks: vaccinate, watch surveillance data, and run clinics. They’re not mutually exclusive, but they do pull in different directions.

What I noticed is that the rhetoric battle can drown out the practical work. When headlines focus on institutional reputations and whether scientists are a new priesthood, fewer eyes may land on clinic schedules, vaccine access, and regional surveillance. It’s a bit like arguing over who should host the neighborhood potluck while the bread still needs to be baked.

At several points this week, authors explicitly worried about that. The Faust pieces and the CDC-watch posts kept nudging the conversation back to evidence and immediate risk. Meanwhile, the political pieces — Tom Church’s subsidy math and Zimmerman’s government critiques — reminded readers that policy choices made now will shape public health in 2026 and beyond.

What people agree on, roughly

You get some surprising agreement, even with all the shouting.

• People generally want better data. Whether you’re on the origins side or the practical side, almost every author nudges for clearer, more transparent information. That’s the rare, easy handshake moment.

• Vaccination still matters. The local clinic snapshot and the surveillance numbers both point to the same thing: shots reduce harm and matter when hospitals start filling. Even the skeptics in other posts admit vaccination is a tool, even if they debate mandates or messaging.

• Policy choices will have consequences. The ACA subsidy negotiations are not an abstract Beltway exercise. They change people’s wallets and access to care. The blog crowd seemed to agree that the fallout from the emergency era will be a policy story for years.

Where the sharp divides lie

The bigger disagreements show up around trust, intent, and how to interpret institutional behavior.

• Origins: some writers insist on keeping lab-leak as a live hypothesis; others emphasize the zoonotic evidence and caution against turning every uncertainty into a scandal. The debate isn’t just about data. It’s about whether certain hypotheses get dismissed too quickly.

• Authority: Knopp’s historical comparison to the Church sits at odds with people who still defend scientific institutions as the best available mechanism for self-correction. One side says peer review is the saving grace. The other says peer review can become an echo chamber.

• Policy framing: Some authors treat COVID-era policy moves as mistakes; others call them necessary responses to an emergency. That divide colors their advice for what to do with subsidies, mandates, and preparedness funding.

Little tangents that stuck with me

• There’s a tiny, almost comic note in this week’s feed: amid space rockets and satellite launches, plenty of writers still found room to throw in a COVID jab. It’s like running into your dentist at the farmer’s market and discovering you both have strong opinions about potholes. It’s not strictly relevant, but it gives the week texture.

• The Thanksgiving thread — food recalls, norovirus, and holiday travel — read like a public-health mixtape. It’s the sort of practical, slightly panicky thing people talk about at family dinners. You don’t want the Thanksgiving table to turn into a hospital waiting room. So a few authors kept nudging readers to take small precautions. That felt human.

Why you might click through

If you want the meat: the Faust posts and the live discussion are the closest thing to a concentrated critique of an established institutional position. They outline why origins still matter and poke at the NIH framing. If you like debates that smell of lab notebooks and email chains, that’s the place to start.

If you want the practical: the surveillance notes and the vaccination-event write-up are where you’ll find concrete, real-world nudges. These pieces tell you what’s rising, where to be careful, and where to find a shot.

If you want the politics and budgets: Tom Church’s piece will read like a primer on how pandemic-era money turns into bargaining chips. That matters if you’re on Medicaid, run a clinic, or simply want to know who gets stuck with the bill.

If you want the cultural critique: Nathan Knopp’s essay gives you the longer arc on institutions and authority. It’s a bit grander in sweep and a little rougher at the edges, but it’s thoughtful in the way a newspaper columnist used to be.

If you’re curious how COVID became a recurring theme in other reporting: Robert Zimmerman’s string of posts show how the pandemic has become a rhetorical pivot for lots of writers, even when the main topic is rockets. It’s a reminder that big events leave fingerprints on unrelated conversations.

A few parting, slightly messy thoughts

I’d say the week doesn’t have a single headline. It has a dozen small ones that echo. There’s a running worry about trust. There’s real, boring-but-important surveillance data showing seasonal upticks. There’s a policy negotiation that will affect people’s insurance. And there’s a persistent desire from some corners to re-open origin questions with dogged curiosity.

It’s like watching three different repair crews show up for a collapsed porch. One measures the beams and checks the nails. Another writes a long memo about who ordered the lumber. The third sells you a plan to roof the house differently. All of them matter. None of them alone fixes the porch.

If you want to dig down, go read the posts. The Faust pieces and the live event notes are probably the most direct route into the origin and institutional critique conversation. Caitlin’s surveillance note is the one to read before you drive to Thanksgiving. Tom’s write-up tells you who’s likely arguing over the checks. And Nathan’s essay gives you something to think about when you’re tired of technical talk and want a little history with your coffee.

There’s more in each post than I can unpack here. But that’s the point — these pieces are invitations. They peek at different parts of the same problem: how a global health shock reshapes science, policy, and daily life. Some of the posts are clinical, some are cranky, some are practical. They don’t all agree. They don’t all need to. They just exist together on the same week’s feed, like it or not.